Antibiotics and fecal transfaunation differentially affect microbiota recovery, associations, and antibiotic resistance in lemur guts.


Journal

Animal microbiome
ISSN: 2524-4671
Titre abrégé: Anim Microbiome
Pays: England
ID NLM: 101759457

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 02 12 2020
accepted: 19 09 2021
entrez: 2 10 2021
pubmed: 3 10 2021
medline: 3 10 2021
Statut: epublish

Résumé

Antibiotics alter the diversity, structure, and dynamics of host-associated microbial consortia, including via development of antibiotic resistance; however, patterns of recovery from microbial imbalances and methods to mitigate associated negative effects remain poorly understood, particularly outside of human-clinical and model-rodent studies that focus on outcome over process. To improve conceptual understanding of host-microbe symbiosis in more naturalistic contexts, we applied an ecological framework to a non-traditional, strepsirrhine primate model via long-term, multi-faceted study of microbial community structure before, during, and following two experimental manipulations. Specifically, we administered a broad-spectrum antibiotic, either alone or with subsequent fecal transfaunation, to healthy, male ring-tailed lemurs (Lemur catta), then used 16S rRNA and shotgun metagenomic sequencing to longitudinally track the diversity, composition, associations, and resistomes of their gut microbiota both within and across baseline, treatment, and recovery phases. Antibiotic treatment resulted in a drastic decline in microbial diversity and a dramatic alteration in community composition. Whereas microbial diversity recovered rapidly regardless of experimental group, patterns of microbial community composition reflected long-term instability following treatment with antibiotics alone, a pattern that was attenuated by fecal transfaunation. Covariation analysis revealed that certain taxa dominated bacterial associations, representing potential keystone species in lemur gut microbiota. Antibiotic resistance genes, which were universally present, including in lemurs that had never been administered antibiotics, varied across individuals and treatment groups. Long-term, integrated study post antibiotic-induced microbial imbalance revealed differential, metric-dependent evidence of recovery, with beneficial effects of fecal transfaunation on recovering community composition, and potentially negative consequences to lemur resistomes. Beyond providing new perspectives on the dynamics that govern host-associated communities, particularly in the Anthropocene era, our holistic study in an endangered species is a first step in addressing the recent, interdisciplinary calls for greater integration of microbiome science into animal care and conservation.

Sections du résumé

BACKGROUND BACKGROUND
Antibiotics alter the diversity, structure, and dynamics of host-associated microbial consortia, including via development of antibiotic resistance; however, patterns of recovery from microbial imbalances and methods to mitigate associated negative effects remain poorly understood, particularly outside of human-clinical and model-rodent studies that focus on outcome over process. To improve conceptual understanding of host-microbe symbiosis in more naturalistic contexts, we applied an ecological framework to a non-traditional, strepsirrhine primate model via long-term, multi-faceted study of microbial community structure before, during, and following two experimental manipulations. Specifically, we administered a broad-spectrum antibiotic, either alone or with subsequent fecal transfaunation, to healthy, male ring-tailed lemurs (Lemur catta), then used 16S rRNA and shotgun metagenomic sequencing to longitudinally track the diversity, composition, associations, and resistomes of their gut microbiota both within and across baseline, treatment, and recovery phases.
RESULTS RESULTS
Antibiotic treatment resulted in a drastic decline in microbial diversity and a dramatic alteration in community composition. Whereas microbial diversity recovered rapidly regardless of experimental group, patterns of microbial community composition reflected long-term instability following treatment with antibiotics alone, a pattern that was attenuated by fecal transfaunation. Covariation analysis revealed that certain taxa dominated bacterial associations, representing potential keystone species in lemur gut microbiota. Antibiotic resistance genes, which were universally present, including in lemurs that had never been administered antibiotics, varied across individuals and treatment groups.
CONCLUSIONS CONCLUSIONS
Long-term, integrated study post antibiotic-induced microbial imbalance revealed differential, metric-dependent evidence of recovery, with beneficial effects of fecal transfaunation on recovering community composition, and potentially negative consequences to lemur resistomes. Beyond providing new perspectives on the dynamics that govern host-associated communities, particularly in the Anthropocene era, our holistic study in an endangered species is a first step in addressing the recent, interdisciplinary calls for greater integration of microbiome science into animal care and conservation.

Identifiants

pubmed: 34598739
doi: 10.1186/s42523-021-00126-z
pii: 10.1186/s42523-021-00126-z
pmc: PMC8485508
doi:

Types de publication

Journal Article

Langues

eng

Pagination

65

Subventions

Organisme : Directorate for Social, Behavioral and Economic Sciences
ID : BCS 1749465

Informations de copyright

© 2021. The Author(s).

Références

Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257956
ISME J. 2012 Aug;6(8):1621-4
pubmed: 22402401
Am J Primatol. 2019 Oct;81(10-11):e22974
pubmed: 30932230
Biol Lett. 2019 Jun 28;15(6):20190028
pubmed: 31185820
Anim Microbiome. 2021 May 18;3(1):39
pubmed: 34006323
Cell Mol Life Sci. 2002 Dec;59(12):2044-54
pubmed: 12568330
Infect Immun. 2012 Jan;80(1):62-73
pubmed: 22006564
Vet Parasitol. 2003 Feb 27;111(4):297-307
pubmed: 12559709
J Travel Med. 2017 Apr 1;24(suppl_1):S35-S38
pubmed: 28520993
Nat Microbiol. 2018 Nov;3(11):1255-1265
pubmed: 30349083
Lancet Infect Dis. 2018 Feb;18(2):132-134
pubmed: 29198739
Microb Ecol. 2016 Nov;72(4):943-954
pubmed: 26984253
Environ Microbiol. 2006 Jul;8(7):1137-44
pubmed: 16817922
ISME J. 2019 Jan;13(1):183-196
pubmed: 30135468
Front Microbiol. 2014 May 20;5:219
pubmed: 24904535
Anat Rec (Hoboken). 2011 Apr;294(4):567-79
pubmed: 21370495
Microorganisms. 2020 Jan 24;8(2):
pubmed: 31991615
PLoS One. 2014 Jul 23;9(7):e102451
pubmed: 25054627
Vet Immunol Immunopathol. 2018 Dec;206:65-72
pubmed: 30502914
Microbiome. 2014 May 05;2:15
pubmed: 24910773
BMC Microbiol. 2019 Oct 22;19(1):230
pubmed: 31640566
Ups J Med Sci. 2014 May;119(2):96-102
pubmed: 24678738
Clin Exp Immunol. 2010 Apr;160(1):70-9
pubmed: 20415854
J Zoo Wildl Med. 2010 Sep;41(3):438-44
pubmed: 20945641
Microbiome. 2021 Jan 23;9(1):26
pubmed: 33485388
Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140087
pubmed: 25918444
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Clin Gastroenterol. 2010 Sep;44(8):551-61
pubmed: 20716985
Mol Microbiol. 2006 May;60(4):820-7
pubmed: 16677295
Infect Immun. 2009 Jun;77(6):2367-75
pubmed: 19307217
Nat Commun. 2016 Jan 26;7:10410
pubmed: 26811868
Science. 2019 Sep 27;365(6460):1405-1409
pubmed: 31604267
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
Nat Commun. 2018 Jul 20;9(1):2872
pubmed: 30030441
Biochem Pharmacol. 2017 Jun 15;134:114-126
pubmed: 27641814
P T. 2015 May;40(5):344-52
pubmed: 25987823
J Antimicrob Chemother. 1981 Dec;8 Suppl D:77-86
pubmed: 7338490
Br J Pharmacol. 2008 Mar;153 Suppl 1:S347-57
pubmed: 18193080
Front Microbiol. 2017 Nov 15;8:2224
pubmed: 29187837
Appl Environ Microbiol. 2001 Feb;67(2):561-8
pubmed: 11157217
Trends Microbiol. 2016 May;24(5):402-413
pubmed: 26996765
Glob Health Epidemiol Genom. 2020 Apr 20;5:e2
pubmed: 32363032
Nat Rev Microbiol. 2010 Apr;8(4):251-9
pubmed: 20190823
Trends Microbiol. 2012 Jul;20(7):313-9
pubmed: 22595318
PLoS One. 2020 Jan 15;15(1):e0226128
pubmed: 31940312
Nat Commun. 2018 May 3;9(1):1786
pubmed: 29725011
PeerJ. 2019 May 27;7:e6876
pubmed: 31179172
Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S19-24
pubmed: 11137404
Cell. 2018 Sep 6;174(6):1406-1423.e16
pubmed: 30193113
Int J Antimicrob Agents. 2001 May;17(5):357-63
pubmed: 11337221
Environ Microbiol. 2009 Dec;11(12):2970-88
pubmed: 19601960
Ciba Found Symp. 1997;207:15-27; discussion 27-35
pubmed: 9189632
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Nat Rev Microbiol. 2014 Sep;12(9):635-45
pubmed: 25118885
Nature. 2011 Aug 31;477(7365):457-61
pubmed: 21881561
Nat Rev Microbiol. 2013 Apr;11(4):277-84
pubmed: 23474681
Am J Primatol. 2018 Jun;80(6):e22867
pubmed: 29862519
Nature. 2000 May 11;405(6783):228-33
pubmed: 10821283
FEMS Microbiol Rev. 2011 Sep;35(5):790-819
pubmed: 21517914
Front Immunol. 2017 Apr 19;8:397
pubmed: 28469619
ISME J. 2019 Mar;13(3):576-587
pubmed: 29995839
Nat Rev Microbiol. 2009 Sep;7(9):629-41
pubmed: 19680247
Gut. 2007 Oct;56(10):1481-2
pubmed: 17872584
Elife. 2013 Apr 16;2:e00458
pubmed: 23599893
Am J Gastroenterol. 2012 Jul;107(7):1079-87
pubmed: 22450732
BMC Infect Dis. 2015 Jul 11;15:265
pubmed: 26159166
Front Microbiol. 2016 Jan 12;6:1543
pubmed: 26793178
Curr Opin Clin Nutr Metab Care. 2016 Sep;19(5):347-352
pubmed: 27341127
Microb Ecol Health Dis. 2017 Jun 15;28(1):1335165
pubmed: 28740461
Horm Behav. 2007 Apr;51(4):555-67
pubmed: 17382329
Genome Med. 2016 Apr 13;8(1):39
pubmed: 27074706
Curr Opin Gastroenterol. 2013 Jan;29(1):79-84
pubmed: 23041678
Methods Mol Biol. 2018;1849:113-129
pubmed: 30298251
Clin Microbiol Infect. 2019 Sep;25(9):1156.e9-1156.e13
pubmed: 30802650
Vet Med (Auckl). 2016 May 31;7:71-74
pubmed: 30050839
Antimicrob Agents Chemother. 2015 Jan;59(1):650-3
pubmed: 25288080
Nature. 2012 Aug 30;488(7413):621-6
pubmed: 22914093
Comput Struct Biotechnol J. 2020 Sep 20;18:2629-2638
pubmed: 33033582
Nutrients. 2012 Aug;4(8):1095-119
pubmed: 23016134
Philos Trans R Soc Lond B Biol Sci. 2020 Sep 28;375(1808):20190604
pubmed: 32772660
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5694-9
pubmed: 24706808
J Clin Microbiol. 2019 Jan 30;57(2):
pubmed: 30429253
Microb Ecol. 2011 Apr;61(3):473-85
pubmed: 21222211
Trends Ecol Evol. 1996 Sep;11(9):372-7
pubmed: 21237882
Curr Opin Allergy Clin Immunol. 2003 Oct;3(5):337-42
pubmed: 14501431
J Immunol Res. 2019 Apr 16;2019:1603758
pubmed: 31143780
Nat Commun. 2014;5:3114
pubmed: 24445449
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
PLoS One. 2014 May 20;9(5):e97699
pubmed: 24846174
ISME J. 2020 Oct;14(10):2625-2645
pubmed: 32632263
Am J Surg. 2018 Oct;216(4):699-705
pubmed: 30100050
J Infect Dis. 1979 Jan;139(1):97-101
pubmed: 108340
Horm Behav. 2010 Jan;57(1):76-85
pubmed: 19804779
Nat Rev Microbiol. 2018 Sep;16(9):567-576
pubmed: 29789680
Nat Rev Microbiol. 2005 Sep;3(9):711-21
pubmed: 16138099
Exp Biol Med (Maywood). 2019 Apr;244(6):494-504
pubmed: 30776908
Mamm Genome. 2014 Feb;25(1-2):49-74
pubmed: 24281320
Cell Metab. 2019 Oct 1;30(4):800-823.e7
pubmed: 31523007
Nature. 2000 May 18;405(6784):299-304
pubmed: 10830951
Chest. 1999 Mar;115(3 Suppl):34S-41S
pubmed: 10084458
Clin Gastroenterol Hepatol. 2011 Dec;9(12):1044-9
pubmed: 21871249
Nat Microbiol. 2020 Sep;5(9):1067-1068
pubmed: 32839573
ISME J. 2009 Nov;3(11):1223-30
pubmed: 19657372
Clin Microbiol Rev. 2007 Oct;20(4):593-621
pubmed: 17934076

Auteurs

Sally L Bornbusch (SL)

Department of Evolutionary Anthropology, Duke University, Durham, USA. sally.bornbusch@gmail.com.

Rachel L Harris (RL)

Department of Evolutionary Anthropology, Duke University, Durham, USA.

Nicholas M Grebe (NM)

Department of Evolutionary Anthropology, Duke University, Durham, USA.

Kimberly Roche (K)

Program in Computational Biology & Bioinformatics, Duke University, Durham, USA.

Kristin Dimac-Stohl (K)

Department of Evolutionary Anthropology, Duke University, Durham, USA.

Christine M Drea (CM)

Department of Evolutionary Anthropology, Duke University, Durham, USA. cdrea@duke.edu.

Classifications MeSH